CA
Cormorant Asset Management, LP cut its CABA stake below 5%
Cormorant Asset Management, LP reported owning 2.6% of Cabaletta Bio, Inc. (CABA) (4,500,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.